Conference Coverage

Drs. David J. Lederer and Fernando J. Martinez address the following topics:

  • How should patients be managed who experience disease progression while on antifibrotic therapy?
  • Is there enough evidence on mortality with antifibrotic therapy to discuss this with patients?


CME/CE Information

Activity Title Applying the Evidence on Antifibrotic Agents for IPF
Topic IPF
Accreditation Type AMA PRA Category 1 Credits
Release Date June 12, 2017
Expiration Date June 13, 2018 – No longer available for credit
Estimated Time to Complete Activity 15 minutes


Upon completion of the activity, participants should be able to:

  • Evaluate new information on agents approved for IPF including combination therapy trials
  • Identify ways in which new information can be applied in the clinical practice setting


David J. Lederer, MD, MS
Associate Professor
Columbia University Medical Center
New York, New York

Fernando J. Martinez, MD, MS
Chief, Division of Pulmonary and Critical Care Medicine
New York Presbyterian Hospital/ Weill Cornell Medical Center
New York, New York


  1. There are no fees for participating in and receiving credit for this activity.
  2. Review the activity objectives and CME/CE information.
  3. Complete the CME/CE activity.
  4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Your CME/CE certificate will be available for download.



This activity is provided by The France Foundation.



This activity is intended for pulmonologists, critical care specialists, hospitalists, fellows and other health care providers who manage patients with IPF.


The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The France Foundation designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME-accredited provider.


In accordance with the ACCME Standards for Commercial Support, The France Foundation requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

The following faculty report that they have relevant financial relationships to disclose:

  • David J. Lederer, MD, MS, has served as a consultant for Boehringer Ingelheim Pharmaceuticals, Inc., Fibrogen, Genentech, Global Blood Therapeutics and Veracyte.
  • Fernando J. Martinez, MD, MS, has served on an advisory board for AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Concert Pharmaceuticals, Inc., Genentech, GlaxoSmithKline, Medical Leverage, Mereo Biopharma Group, Novartis Pharmaceuticals Corporation, Pearl Therapeutics, Inc., ProterixBio Inc., Theravance Biopharma, and Veracyte, Inc. Contracted Research for Afferent Pharmaceuticals, AstraZeneca, Biogen, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Gilead Sciences Medical Affairs, GlaxoSmithKline, and Veracyte, Inc. Speaker’s Bureau for AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, National Association for Continuing Education Inc., Novartis Pharmaceuticals Corporation, PeerView, Inc., Potomac Pharma Inc., Prime Pharma, UpTo Date, Inc., and WebMD.


TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.


This activity is supported by an educational grant from Genentech.


The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.


Copyright © 2017 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

  • The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
  • Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.


The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation's Privacy Policy can be viewed at


If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or This email address is being protected from spambots. You need JavaScript enabled to view it..